2024 Conference Coverage


 

Multi-Institutional Study of Neurologic Outcomes in People With Multiple Sclerosis Who Are Treated With Immune Checkpoint Inhibitors (ICIs) for Oncologic Indications

66 views
May 8, 2024
1 Comment
Login to view comments. Click here to Login
Videos